The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis

BACKGROUND: Anti-type 2 inflammation therapy has been proposed as a treatment strategy for eosinophil-associated chronic airway disorders that could reduce exacerbations and improve lung function. We performed a meta-analysis of randomized controlled trials to assess the effectiveness of type 2 mono...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuan, Huang, Mengfen, Zhong, Jinyao, Lu, Yue, Gan, Kao, Yang, Rongyuan, Liu, Yuntao, Li, Jiqiang, Chen, Jiankun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126252/
https://www.ncbi.nlm.nih.gov/pubmed/37114057
http://dx.doi.org/10.3389/fimmu.2023.1089710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126252/
https://www.ncbi.nlm.nih.gov/pubmed/37114057
http://dx.doi.org/10.3389/fimmu.2023.1089710

Ejemplares similares